Showing results (2011-2020 of 5,146) with videos related to

Sort By:
Pageof 515
Multiple Sclerosis and Related Disorders|July 11, 2020
Multiple sclerosis and neuromyelitis optica after optic neuritis: A nationwide cohort study in TaiwanWei-Sheng Lin, Ho-Min Chen, Chih-Chao Yang, et al.
Multiple Sclerosis and Related Disorders|July 11, 2020
Co-incident primary progressive multiple sclerosis and hereditary spastic paraplegia (SPG4) - a case reportJohn J Boucher, Timothy J Counihan
Multiple Sclerosis and Related Disorders|July 24, 2020
Promising recovery biomarkers after first event acute demyelinating optic neuritisS Klineova, M Kupersmith
Multiple Sclerosis and Related Disorders|July 25, 2020
Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disordersVelina S Chavarro, Judith Bellmann-Strobl, Hanna G Zimmermann, et al.
Multiple Sclerosis and Related Disorders|July 26, 2020
Investigation of the "central vein sign" in infratentorial multiple sclerosis lesionsClaudia E Weber, Vesile Sandikci, Anne Ebert, et al.
Multiple Sclerosis and Related Disorders|July 3, 2020
A case of possible atypical demyelinating event of the central nervous system following COVID-19Anahita Zoghi, Mahtab Ramezani, Mehrdad Roozbeh, et al.
Multiple Sclerosis and Related Disorders|July 3, 2020
Atypical MOG antibody disease presenting with typical multiple sclerosis lesionsKatelyn Dolbec, Joshua Chalkley, Padmaja Sudhakar
Multiple Sclerosis and Related Disorders|July 6, 2020
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case reportJan Kolcava, Jiri Litzman, Josef Bednarik, et al.
Multiple Sclerosis and Related Disorders|July 5, 2020
Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumabJeanine Rempe Thornton, Asaff Harel
Multiple Sclerosis and Related Disorders|July 31, 2020
Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of AmericaRichard K Burt, Paul Tappenden, Xiaoqiang Han, et al.
Pageof 515